Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.

Pan Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, Symmons DPM, Lunt M, Young A; BSRBR-RA Control Centre Consortium, Hyrich KL, Verstappen SMM.

PLoS One. 2019 May 20;14(5):e0215999. doi: 10.1371/journal.pone.0215999. eCollection 2019.

2.

A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?

Jones C, Verstappen SMM, Payne K.

Appl Health Econ Health Policy. 2019 Apr 1. doi: 10.1007/s40258-019-00473-8. [Epub ahead of print] Review.

PMID:
30937837
3.

Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group.

Verstappen SMM, Lacaille D, Boonen A, Escorpizo R, Hofstetter C, Bosworth A, Leong A, Leggett S, Gignac MAM, Wallman JK, Terwee MM, Berghea F, Agaliotis M, Tugwell P, Beaton D.

J Rheumatol. 2019 Apr 1. pii: jrheum.181201. doi: 10.3899/jrheum.181201. [Epub ahead of print]

PMID:
30936275
4.

Comparing Proxy, Adolescent and Adult Assessments of Functional Ability in Adolescents with Juvenile Idiopathic Arthritis.

Shoop-Worrall SJW, Hyrich KL, Verstappen SM, Sergeant JC, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, McDonagh JE.

Arthritis Care Res (Hoboken). 2019 Mar 15. doi: 10.1002/acr.23877. [Epub ahead of print]

PMID:
30875458
5.

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Hensor EMA, McKeigue P, Ling SF, Colombo M, Barrett JH, Nam JL, Freeston J, Buch MH, Spiliopoulou A, Agakov F, Kelly S, Lewis MJ, Verstappen SMM, MacGregor AJ, Viatte S, Barton A, Pitzalis C, Emery P, Conaghan PG, Morgan AW.

Rheumatology (Oxford). 2019 Mar 1. pii: kez049. doi: 10.1093/rheumatology/kez049. [Epub ahead of print]

6.

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease.

Hope HF, Binkley GM, Fenton S, Kitas GD, Verstappen SMM, Symmons DPM.

PLoS One. 2019 Jan 17;14(1):e0201196. doi: 10.1371/journal.pone.0201196. eCollection 2019.

7.

Overview of changes in RMD epidemiology and outcome development in the last 10 years.

Verstappen SMM, Carmona L.

Best Pract Res Clin Rheumatol. 2018 Apr;32(2):169-173. doi: 10.1016/j.berh.2018.10.008. Epub 2018 Nov 17.

PMID:
30527424
8.

Epidemiology of rheumatic and musculoskeletal diseases.

Verstappen SMM, Carmona L.

Best Pract Res Clin Rheumatol. 2018 Apr;32(2):167-168. doi: 10.1016/j.berh.2018.11.002. No abstract available.

PMID:
30527423
9.

Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis.

Alemao E, Al MJ, Boonen AA, Stevenson MD, Verstappen SMM, Michaud K, Weinblatt ME, Rutten-van Mölken MPMH.

PLoS One. 2018 Oct 5;13(10):e0205013. doi: 10.1371/journal.pone.0205013. eCollection 2018.

10.

The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank.

Cook MJ, Bellou E, Bowes J, Sergeant JC, O'Neill TW, Barton A, Verstappen SMM.

Rheumatology (Oxford). 2018 Dec 1;57(12):2172-2182. doi: 10.1093/rheumatology/key224.

11.

Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).

Sergeant JC, Hyrich KL, Anderson J, Kopec-Harding K, Hope HF, Symmons DPM; RAMS Co-Investigators, Barton A, Verstappen SMM.

Arthritis Res Ther. 2018 Jul 13;20(1):147. doi: 10.1186/s13075-018-1645-5.

12.

Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients.

Taylor JC, Bongartz T, Massey J, Mifsud B, Spiliopoulou A, Scott IC, Wang J, Morgan M, Plant D, Colombo M, Orchard P, Twigg S, McInnes IB, Porter D, Freeston JE, Nam JL, Cordell HJ, Isaacs JD, Strathdee JL, Arnett D, de Hair MJH, Tak PP, Aslibekyan S, van Vollenhoven RF, Padyukov L, Bridges SL, Pitzalis C, Cope AP, Verstappen SMM, Emery P, Barnes MR, Agakov F, McKeigue P, Mushiroda T, Kubo M, Weinshilboum R, Barton A, Morgan AW, Barrett JH; MATURA; and PAMERA; Consortia.

Pharmacogenomics J. 2018 Jul;18(4):528-538. doi: 10.1038/s41397-018-0025-5. Epub 2018 May 25. Review.

13.

Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review.

Gwinnutt JM, Sharp CA, Symmons DPM, Lunt M, Verstappen SMM.

Semin Arthritis Rheum. 2018 Dec;48(3):384-398. doi: 10.1016/j.semarthrit.2018.03.004. Epub 2018 Mar 15.

14.

Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition.

Shoop-Worrall SJW, Verstappen SMM, McDonagh JE, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.

Arthritis Rheumatol. 2018 Sep;70(9):1519-1529. doi: 10.1002/art.40519. Epub 2018 Jul 22.

15.

Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study.

Bluett J, Sergeant JC, MacGregor AJ, Chipping JR, Marshall T, Symmons DPM, Verstappen SMM.

Arthritis Res Ther. 2018 Mar 20;20(1):50. doi: 10.1186/s13075-018-1544-9.

16.

Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register.

Gwinnutt JM, Symmons DPM, MacGregor AJ, Chipping JR, Marshall T, Lunt M, Verstappen SMM.

Ann Rheum Dis. 2018 Jun;77(6):848-854. doi: 10.1136/annrheumdis-2017-212426. Epub 2018 Feb 23.

17.

Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept.

Generali E, Carrara G, Selmi C, Verstappen SMM, Zambon A, Bortoluzzi A, Silvagni E, Scirè CA.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):310-313. Epub 2017 Dec 28.

18.

Patterns of pain over time among children with juvenile idiopathic arthritis.

Rashid A, Cordingley L, Carrasco R, Foster HE, Baildam EM, Chieng A, Davidson JE, Wedderburn LR, Ioannou Y, McErlane F, Verstappen SMM, Hyrich KL, Thomson W.

Arch Dis Child. 2018 May;103(5):437-443. doi: 10.1136/archdischild-2017-313337. Epub 2017 Nov 25.

19.

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

Yamanaka H, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Novelli Horne L, Inoue E, Michaud K, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SMM, Wesby-van Swaay E, Nyberg F.

RMD Open. 2017 Oct 10;3(2):e000498. doi: 10.1136/rmdopen-2017-000498. eCollection 2017.

20.

Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study.

Marques A, Lucas R, Simões E, Verstappen SMM, Jacobs JWG, da Silva JAP.

RMD Open. 2017 Sep 26;3(2):e000509. doi: 10.1136/rmdopen-2017-000509. eCollection 2017.

21.

Reply.

Gwinnutt JM, Symmons DPM, Lunt M, Verstappen SMM.

Arthritis Rheumatol. 2017 Dec;69(12):2402-2403. doi: 10.1002/art.40311. Epub 2017 Nov 2. No abstract available.

22.

How common is remission in juvenile idiopathic arthritis: A systematic review.

Shoop-Worrall SJW, Kearsley-Fleet L, Thomson W, Verstappen SMM, Hyrich KL.

Semin Arthritis Rheum. 2017 Dec;47(3):331-337. doi: 10.1016/j.semarthrit.2017.05.007. Epub 2017 May 20. Review.

23.

Response to: Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis by Kremer and Weinblatt.

Humphreys JH, Costello R, Verstappen SM, Dixon WG.

Ann Rheum Dis. 2018 Jan;77(1):e5. doi: 10.1136/annrheumdis-2017-211670. Epub 2017 Jun 8. No abstract available.

PMID:
28596185
24.

Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years.

Gwinnutt JM, Symmons DPM, MacGregor AJ, Chipping JR, Lapraik C, Marshall T, Lunt M, Verstappen SMM.

Rheumatology (Oxford). 2017 Sep 1;56(9):1510-1517. doi: 10.1093/rheumatology/kex172.

25.

HLA-A 31:01 is not associated with the development of methotrexate pneumonitis in the UK population: results from a genome-wide association study.

Bluett J, Owen SA, Massey J, Alfirevic A, Pirmohamed M, Plant D, Verstappen SMM, Barton A; Pneumonitis Study Consortium.

Ann Rheum Dis. 2017 Dec;76(12):e51. doi: 10.1136/annrheumdis-2017-211512. Epub 2017 May 12. No abstract available.

PMID:
28500057
26.

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.

Finger ME, Boonen A, Woodworth TG, Escorpizo R, Christensen R, Nielsen SM, Leong AL, Scholte Voshaar M, Flurey CA, Milman N, Verstappen SM, Alten R, Guillemin F, Kloppenburg M, Beaton DE, Tugwell PS, March LM, Furst DE, Pohl C.

J Rheumatol. 2017 Nov;44(11):1734-1739. doi: 10.3899/jrheum.161200. Epub 2017 May 1.

PMID:
28461648
27.

Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.

Gwinnutt JM, Symmons DPM, MacGregor AJ, Chipping JR, Marshall T, Lunt M, Verstappen SMM.

Arthritis Rheumatol. 2017 Aug;69(8):1566-1575. doi: 10.1002/art.40090. Epub 2017 Jul 10.

28.

How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.

Shoop-Worrall SJW, Verstappen SMM, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.

Ann Rheum Dis. 2017 Aug;76(8):1381-1388. doi: 10.1136/annrheumdis-2016-210511. Epub 2017 Apr 7. Erratum in: Ann Rheum Dis. 2017 Oct;76(10):1783-1784.

29.

Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.

Humphreys JH, Warner A, Costello R, Lunt M, Verstappen SMM, Dixon WG.

Ann Rheum Dis. 2017 Sep;76(9):1509-1514. doi: 10.1136/annrheumdis-2016-210629. Epub 2017 Mar 23.

30.

The impact of socio-economic status in rheumatoid arthritis.

Verstappen SMM.

Rheumatology (Oxford). 2017 Jul 1;56(7):1051-1052. doi: 10.1093/rheumatology/kew428. No abstract available.

PMID:
27940587
31.

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.

van Wesemael TJ, Ajeganova S, Humphreys J, Terao C, Muhammad A, Symmons DP, MacGregor AJ, Hafström I, Trouw LA, van der Helm-van Mil AH, Huizinga TW, Mimori T, Toes RE, Matsuda F, Svensson B, Verstappen SM, van der Woude D.

Arthritis Res Ther. 2016 Dec 1;18(1):285.

32.

Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.

Cook MJ, Diffin J, Scirè CA, Lunt M, MacGregor AJ, Symmons DP, Verstappen SM.

Rheumatology (Oxford). 2016 Sep;55(9):1601-9. doi: 10.1093/rheumatology/kew210. Epub 2016 May 24.

33.

Response to: 'Evaluation of the association between anticarbamylated protein antibodies and longitudinal course of functional ability in rheumatoid arthritis' by Ajeganova et al.

Humphreys JH, Symmons DP, Verstappen SM.

Ann Rheum Dis. 2016 Apr;75(4):e15. doi: 10.1136/annrheumdis-2015-208957. Epub 2016 Feb 18. No abstract available.

PMID:
26893487
34.

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.

Michaud K, Berglind N, Franzén S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Horne L, Inoue E, Nyberg F, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SM, Wesby-van Swaay E, Yamanaka H, Askling J.

Ann Rheum Dis. 2016 Oct;75(10):1797-805. doi: 10.1136/annrheumdis-2015-208698. Epub 2016 Feb 8.

PMID:
26857699
35.

Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes.

Hope HF, Bluett J, Barton A, Hyrich KL, Cordingley L, Verstappen SM.

RMD Open. 2016 Jan 20;2(1):e000171. doi: 10.1136/rmdopen-2015-000171. eCollection 2016. Review.

36.

Content validity of global measures for at-work productivity in patients with rheumatic diseases: an international qualitative study.

Leggett S, van der Zee-Neuen A, Boonen A, Beaton D, Bojinca M, Bosworth A, Dadoun S, Fautrel B, Hagel S, Hofstetter C, Lacaille D, Linton D, Mihai C, Petersson IF, Rogers P, Sciré C, Verstappen SM; at-work productivity global measure working group.

Rheumatology (Oxford). 2016 Aug;55(8):1364-73. doi: 10.1093/rheumatology/kev435. Epub 2016 Jan 21.

PMID:
26796771
37.

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.

Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.

Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.

PMID:
26757747
38.

Test-retest Reliability and Correlations of 5 Global Measures Addressing At-work Productivity Loss in Patients with Rheumatic Diseases.

Leggett S, van der Zee-Neuen A, Boonen A, Beaton DE, Bojinca M, Bosworth A, Dadoun S, Fautrel B, Hagel S, Hofstetter C, Lacaille D, Linton D, Mihai C, Petersson IF, Rogers P, Sergeant JC, Sciré C, Verstappen SM; At-work Productivity Global Measure Working Group.

J Rheumatol. 2016 Feb;43(2):433-9. doi: 10.3899/jrheum.141605. Epub 2015 Dec 1.

PMID:
26628608
39.

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.

Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Horne L, Inoue E, Michaud K, Nyberg F, Pappas DA, Reed G, Tanaka E, Tran TN, Verstappen SM, Yamanaka H, Wesby-van Swaay E, Symmons D.

Ann Rheum Dis. 2016 Oct;75(10):1789-96. doi: 10.1136/annrheumdis-2015-208105. Epub 2015 Nov 30.

PMID:
26621482
40.

Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.

Verstappen SM.

Best Pract Res Clin Rheumatol. 2015 Jun;29(3):495-511. doi: 10.1016/j.berh.2015.06.001. Epub 2015 Jul 14. Review.

PMID:
26612244
41.

The Longitudinal Course of Fatigue in Rheumatoid Arthritis: Results from the Norfolk Arthritis Register.

Druce KL, Jones GT, Macfarlane GJ, Verstappen SM, Basu N.

J Rheumatol. 2015 Nov;42(11):2059-65. doi: 10.3899/jrheum.141498. Epub 2015 Oct 15.

PMID:
26472420
42.

Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.

Humphreys JH, Verheul MK, Barton A, MacGregor AJ, Lunt M, Toes RE, Symmons DP, Trouw LA, Verstappen SM.

Ann Rheum Dis. 2016 Jun;75(6):1139-44. doi: 10.1136/annrheumdis-2015-207326. Epub 2015 Oct 6.

43.

OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.

Beaton DE, Dyer S, Boonen A, Verstappen SM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MA, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, Bombardier C, Tugwell PS.

J Rheumatol. 2016 Jan;43(1):214-22. doi: 10.3899/jrheum.141077. Epub 2015 Sep 1. Review.

PMID:
26329339
44.

Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.

Nyberg F, Askling J, Berglind N, Franzén S, Ho M, Holmqvist M, Horne L, Lampl K, Michaud K, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SM, Wesby-van Swaay E, Yamanaka H, Greenberg JD.

Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1121-32. doi: 10.1002/pds.3854. Epub 2015 Aug 25.

PMID:
26303866
45.

Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.

Verstappen SM, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Holmqvist M, Horne L, Lampl K, Michaud K, Nyberg F, Pappas DA, Reed G, Symmons DP, Tanaka E, Tran TN, Yamanaka H, Ho M.

Arthritis Care Res (Hoboken). 2015 Dec;67(12):1637-45. doi: 10.1002/acr.22661.

46.

Direct health costs of inflammatory polyarthritis 10 years after disease onset: results from the Norfolk Arthritis Register.

Nikiphorou E, Davies C, Mugford M, Cooper N, Brooksby A, Bunn DK, Young A, Verstappen SM, Symmons DP, MacGregor AJ.

J Rheumatol. 2015 May;42(5):794-8. doi: 10.3899/jrheum.140528. Epub 2015 Apr 1.

PMID:
25834202
47.

A HPLC-SRM-MS based method for the detection and quantification of methotrexate in urine at doses used in clinical practice for patients with rheumatological disease: a potential measure of adherence.

Bluett J, Riba-Garcia I, Hollywood K, Verstappen SM, Barton A, Unwin RD.

Analyst. 2015 Mar 21;140(6):1981-7. doi: 10.1039/c4an02321h.

PMID:
25671614
48.

Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.

Humphreys JH, van Nies JA, Chipping J, Marshall T, van der Helm-van Mil AH, Symmons DP, Verstappen SM.

Arthritis Res Ther. 2014 Dec 4;16(6):483. doi: 10.1186/s13075-014-0483-3.

49.

How do we classify rheumatoid arthritis in established disease--can we apply the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria?

Humphreys JH, Verstappen SM, Scire CA, Uhlig T, Fautrel B, Sokka T, Symmons DP.

J Rheumatol. 2014 Dec;41(12):2347-51. doi: 10.3899/jrheum.141443. No abstract available.

PMID:
25452179
50.

The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study.

Verstappen SM, Cobb J, Foster HE, Fu B, Baildam E, Wedderburn LR, Davidson JE, Ioannou J, Chieng A, Hyrich KL, Thomson W.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):382-9. doi: 10.1002/acr.22466.

Supplemental Content

Loading ...
Support Center